Skip to content

Author

M. Saei Ghare Naz

We have 4 of 69 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

The Effect of Polycystic Ovarian Syndrome on Development of Diabetes Mellitus by a Multistate Modelling Approach

Women with polycystic ovary syndrome (PCOS) are more susceptible to metabolic dysfunction, especially glucose impairment. Previous studies have considered prediabetes (pre‐DM) and diabetes mellitus (DM) as single‐point outcomes without accounting for the transition states. This study aimed to explore the transition bet...

Maryam Mousavi, M. Saei Ghare Naz, M. Noroozzadeh et al. · 1 citation
Review Open access Sep 2026

Polycystic Ovary Syndrome and Subjective and Objective Assessments of Sleep Quality: A Systematic Review and Meta‐Analysis

Sleep disturbances are increasingly recognized in women with polycystic ovary syndrome (PCOS), but the evidence remains inconsistent. We conducted a meta‐analysis to evaluate objective sleep abnormalities and subjective sleep complaints in women with PCOS.

A. Tabashiri, Pourya Kanani, M. Saei Ghare Naz et al. · 0 citations
Review Open access Aug 2026

Endometriosis-associated bone loss: re-evaluating the potential role of systemic inflammation and hypoestrogenic therapies

Endometriosis is frequently managed with hormonal suppression that can induce hypoestrogenism during a period when many patients are still accruing peak bone mass. This narrative review summarizes current clinical and mechanistic evidence on bone health in endometriosis and its treatments and discusses a preliminary co...

F. Motafeghi, M. Saei Ghare Naz, F. Ramezani Tehrani et al. · 0 citations
Open access Jul 2026

Anti‐Müllerian Hormone and Metabolic–Hormonal Profiles in Women With and Without Polycystic Ovary Syndrome: A Population‐Based Study

Higher AMH may be protective against T2DM in older healthy women but indicates elevated metabolic risk in younger women with PCOS, suggesting that AMH may serve as a life‐course biomarker for metabolic risk stratification and personalized preventive strategies in women's healthcare.

F. Ramezani Tehrani, Maryam Mousavi, M. Saei Ghare Naz et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.